サマリー

ドイツ、スウェーデン、フィンランド、イギリスの遠隔医療＆eヘルス市場は、2023年の532億2750万米ドルから2031年には1億810億2261万米ドルに達すると予測され、2024年から2031年の予測期間には年平均成長率17.6％で成長する。
市場区分
ドイツ、スウェーデン、フィンランド、イギリスの遠隔医療・Eヘルス市場：タイプ別（Eヘルス、遠隔医療）、提供形態別（クラウドベース、オンプレミス）、用途別（遠隔診察、慢性疾患管理、遠隔モニタリング、在宅医療、遠隔治療、メンタルヘルスサービス、投薬管理、遠隔薬物療法サービス、医療教育とトレーニング、その他）、エンドユーザー（医療提供者、医療消費者（患者）、高齢者介護施設、外来手術センター（ASC）、診断センター、その他）、国（ドイツ、スウェーデン、フィンランド、英国） - 2031年までの産業動向と予測
ドイツ、スウェーデン、フィンランド、イギリスの遠隔医療・Eヘルス市場ダイナミクスの概要

促進要因
- メンタルヘルスサービスに対する需要の高まり

抑制要因
- 熟練した専門家の不足

機会
- パーソナライズされたソリューションのためのAI統合メンタルヘルス・プラットフォーム

市場プレイヤー

ドイツ、スウェーデン、フィンランド、イギリスの遠隔医療・eヘルス市場の主要な市場プレイヤーは以下の通り：
- エベロン
- エイダ・ヘルス社
- アヴィ・メディカル社
- arztkonsultation ak GmbH
- テレクリニック社
- メディキットドック
- クライ・インターナショナルAB
- 遠隔医療クリニック
- Doktorse Nordic AB
- ORTIVUS AB
- ニアヘルス社
- メドループ社
- ハートビートラボ
- コンシルメッド

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.3 OVERVIEW OF THE GERMANY, SWEDEN, FINLAND AND GREAT BRITAIN TELEMEDICINE AND E-HEALTH MARKET 22
1.4 CURRENCY AND PRICING 23
1.5 LIMITATIONS 24
1.6 MARKETS COVERED 24
2 MARKET SEGMENTATION 29
2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 DBMR TRIPOD DATA VALIDATION MODEL 32
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
2.6 MULTIVARIATE MODELLING 36
2.7 TYPE SEGMENT LIFELINE CURVE 36
2.8 MARKET END USER COVERAGE GRID 37
2.9 DBMR MARKET POSITION GRID 38
2.10 VENDOR SHARE ANALYSIS 39
2.11 SECONDARY SOURCES 40
2.12 ASSUMPTIONS 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 43
4.1 PESTEL ANALYSIS 44
4.2 PORTER FIVE FORCES 45
5 GERMANY, SWEDEN, FINLAND, GREAT BRITAIN TELEMEDICINE AND E-HEALTH MARKET: REGULATIONS 46
5.1 REGULATIONS IN GERMANY 46
5.2 REGULATIONS IN SWEDEN 47
5.3 REGULATIONS IN FINLAND 47
5.4 REGULATTIONS IN GREAT BRITAIN 47
6 MARKET OVERVIEW 48
6.1 DRIVERS 50
6.1.1 RISING DEMAND FOR MENTAL HEALTH SERVICES 50
6.1.2 RISING NEED FOR RADIOLOGICAL SERVICES 50
6.1.3 GOVERNMENT INITIATIVES PROMOTING ADVANCED HEALTHCARE INFRASTRUCTURE 51
6.1.4 GROWING PREFERENCE FOR ONLINE CONSULTATION 52
6.2 RESTRAINTS 52
6.2.1 LACK OF SKILLED PROFESSIONALS 52
6.2.2 HIGH COST ASSOCIATED WITH HEALTHCARE IT TOOLS 53
6.3 OPPORTUNITIES 53
6.3.1 AI-INTEGRATED MENTAL HEALTH PLATFORMS FOR PERSONALIZED SOLUTIONS 53
6.3.2 DEVELOPING EASILY ACCESSIBLE AND WIDELY ADOPTED MHEALTH APPLICATIONS 54
6.3.3 IMPLEMENTING ADVANCED DATA ANALYTICS FOR PREDICTIVE HEALTHCARE MODELS 54
6.4 CHALLENGES 55
6.4.1 RISKS OF CYBER ATTACKS ON TELEMEDICINE PLATFORMS, COMPROMISING PATIENT PRIVACY 55
6.4.2 RESISTANCE WHILE INTEGRATING TELEMEDICINE INTO TRADITIONAL HEALTHCARE SYSTEMS 56
7 GERMANY, SWEDEN, FINLAND AND GREAT BRITAIN TELEMEDICINE AND E-HEALTH MARKET, BY TYPE 57
7.1 OVERVIEW 58
7.2 E-HEALTH 61
7.3 TELEMEDICINE 69
8 GERMANY, SWEDEN, FINLAND AND GREAT BRITAIN TELEMEDICINE AND E-HEALTH MARKET, BY DELIVERY MODE 75
8.1 OVERVIEW 76
8.2 CLOUD-BASED 79
8.3 ON-PREMISE 79
9 GERMANY, SWEDEN, FINLAND AND GREAT BRITAIN TELEMEDICINE AND E-HEALTH MARKET, BY APPLICATION 80
9.1 OVERVIEW 81
9.2 REMOTE CONSULTATIONS 84
9.3 CHRONIC DISEASE MANAGEMENT 84
9.4 TELEMONITORING 84
9.5 HOME HEALTH CARE 84
9.6 TELETHERAPY AND MENTAL HEALTH SERVICES 85
9.7 MEDICATION MANAGEMENT 85
9.8 TELEPHARMACY SERVICES 85
9.9 MEDICAL EDUCATION AND TRAINING 85
9.10 OTHERS 85
10 GERMANY, SWEDEN, FINLAND AND GREAT BRITAIN TELEMEDICINE AND E-HEALTH MARKET, BY END USER 86
10.1 OVERVIEW 87
10.2 HEALTHCARE PROVIDERS 90
10.3 HEALTHCARE CONSUMERS (PATIENTS) 91
10.4 SENIOR CARE FACILITIES 91
10.5 AMBULATORY SURGICAL CENTERS (ASCS) 91
10.6 DIAGNOSTIC CENTERS 91
10.7 OTHERS 91
11 GERMANY, SWEDEN, FINLAND AND GREAT BRITAIN TELEMEDICINE AND E-HEALTH MARKET, BY COUNTRY 92
11.1 GREAT BRITAIN 93
11.2 GERMANY 107
11.3 SWEDEN 121
11.4 FINLAND 136
12 GERMANY, SWEDEN, FINLAND, GREAT BRITAIN TELEMEDICINE AND E-HEALTH MARKET, COMPANY LANDSCAPE 151
12.1 COMPANY SHARE ANALYSIS: GERMANY 151
12.2 COMPANY SHARE ANALYSIS: SWEDEN 152
12.3 COMPANY SHARE ANALYSIS: GREAT BRITAIN 153
12.4 COMPANY SHARE ANALYSIS: FINLAND 154
13 SWOT ANALYSIS 155
14 COMPANY PROFILES 156
14.1 ADA HEALTH GMBH 156
14.1.1 COMPANY SNAPSHOT 156
14.1.2 PRODUCT PORTFOLIO 156
14.1.3 RECENT DEVELOPMENT 157
14.2 ARZTKONSULTATION AK GMBH 158
14.2.1 COMPANY SNAPSHOT 158
14.2.2 SERVICE PORTFOLIO 158
14.2.3 RECENT DEVELOPMENT 159
14.3 AVI MEDICAL GMBH 160
14.3.1 COMPANY SNAPSHOT 160
14.3.2 PRODUCT PORTFOLIO 160
14.3.3 RECENT DEVELOPMENT 160
14.4 DOKTORSE NORDIC AB 161
14.4.1 COMPANY SNAPSHOT 161
14.4.2 PRODUCT PORTFOLIO 161
14.4.3 RECENT DEVELOPMENTS 161
14.5 EVERON 162
14.5.1 COMPANY SNAPSHOT 162
14.5.2 PRODUCT PORTFOLIO 162
14.5.3 RECENT DEVELOPMENT 163
14.6 HEARTBEAT LABS GMBH 164
14.6.1 COMPANY SNAPSHOT 164
14.6.2 SERVICE PORTFOLIO 164
14.6.3 RECENT DEVELOPMENT 164
14.7 KONSILMED 165
14.7.1 COMPANY SNAPSHOT 165
14.7.2 SERVICE PORTFOLIO 165
14.7.3 RECENT DEVELOPMENTS 165
14.8 KRY INTERNATIONAL AB 166
14.8.1 COMPANY SNAPSHOT 166
14.8.2 SERVICE PORTFOLIO 166
14.8.3 RECENT DEVELOPMENT 166
14.9 MEDKITDOC 167
14.9.1 COMPANY SNAPSHOT 167
14.9.2 SERVICE PORTFOLIO 167
14.9.3 RECENT DEVELOPMENTS 167
14.10 MEDLOOP LTD. 168
14.10.1 COMPANY SNAPSHOT 168
14.10.2 SERVICE PORTFOLIO 168
14.10.3 RECENT DEVELOPMENTS 168
14.11 NIA HEALTH GMBH 169
14.11.1 COMPANY SNAPSHOT 169
14.11.2 PRODUCT PORTFOLIO 169
14.11.3 RECENT DEVELOPMENT 170
14.12 ORTIVUS AB 171
14.12.1 COMPANY SNAPSHOT 171
14.12.2 PRODUCT PORTFOLIO 171
14.12.3 RECENT DEVELOPMENTS 172
14.13 TELECLINIC GMBH 173
14.13.1 COMPANY SNAPSHOT 173
14.13.2 SERVICE PORTFOLIO 173
14.13.3 RECENT DEVELOPMENTS 173
14.14 TELEMEDICINE CLINIC 174
14.14.1 COMPANY SNAPSHOT 174
14.14.2 PRODUCT PORTFOLIO 174
14.14.3 RECENT DEVELOPMENT 174
15 QUESTIONNAIRE 175
16 RELATED REPORTS 178